How do I choose between different contract manufacturing providers for a new generic product?

Choosing a contract manufacturing organization (CMO) for a new generic product is mostly about balancing technical fit, regulatory confidence, supply reliability, and economics. A low-cost quote is only helpful if the partner can consistently make an approvable, scalable, and profitable product.

Here’s a practical way to evaluate providers.

1) Start with the product requirements

Before comparing CMOs, define what the product actually needs:

• Dosage form: tablet, capsule, cream, sterile liquid, inhalation, etc.
• API characteristics: potency, solubility, hygroscopicity, handling controls, OEB/OEL requirements
• Complexity: immediate release vs. modified release, low-dose, sterile, controlled substance, etc.
• Target markets: US, EU, UK, Canada, emerging markets
• Volume forecast: launch volumes, steady-state demand, growth plan
• Regulatory status: ANDA, EU generic filing, DMF dependency, CEP, site approvals
• Packaging needs: blister, bottle, sachet, cold chain, serialization

A CMO that is excellent for one product type may be a poor fit for another.

2) Check technical capability first

This is usually the biggest filter.

Ask whether the provider has:

• The right unit operations for your formulation
• Experience with similar products
• Process development and scale-up capability
• Analytical support for method validation, stability, and QC release
• Troubleshooting expertise if the first process doesn’t transfer cleanly
• Equipment scale that matches your current and future demand

For generic products, look for evidence they’ve handled:

• Formulation transfers
• Bioequivalence-supporting manufacturing
• Process validation at commercial scale
• Routine change control without disrupting product quality

If they cannot explain how they would make your product robustly, that is a warning sign.

3) Evaluate regulatory and quality track record

A low-cost supplier with weak compliance can become extremely expensive.

Review:

• FDA/EMA inspection history
• 483s, warning letters, import alerts, or major findings
• CAPA quality
• Deviation and complaint handling
• Data integrity controls
• Ongoing audit readiness
• Track record with product registrations and variations

Ask:

• How many similar products have they supported successfully?
• Have they hosted inspections for comparable dosage forms?
• How do they manage investigations and root cause analysis?
• What is their batch rejection and OOS trend?

If possible, request recent audit summaries or third-party audit reports.

4) Understand supply chain risk

A CMO is not just a factory; it’s a supply chain partner.

Assess:

• API sourcing strategy
• Number of qualified raw material suppliers
• Geographic concentration risk
• Lead times and safety stock practices
• Business continuity planning
• Single-point-of-failure equipment or utilities
• Capacity reservation and surge capability

For generics, consistency and availability matter a lot. If a provider cannot support stable supply, you may lose market share quickly.

5) Compare economics on total cost, not unit price

A quoted manufacturing cost can hide major downstream costs.

Look at:

• Tech transfer cost
• Validation and launch batch costs
• Minimum order quantities
• Inventory carrying cost
• Freight and import duties
• Testing and release expenses
• Change-control charges
• Expedite fees
• Cost of poor quality
• Cost of delays to market

The best CMO is often the one with the lowest total landed cost and lowest risk-adjusted cost, not the lowest per-unit price.

6) Assess project management and communication

A strong technical partner can still be a bad operating partner if communication is poor.

Look for:

• Clear timeline and milestones
• Dedicated project manager
• Fast response times
• Transparency about risks and constraints
• Good documentation practices
• Strong cross-functional coordination between manufacturing, QA, QC, and supply chain

During the selection process, pay attention to how they behave:

• Do they answer questions directly?
• Do they admit limitations?
• Do they escalate issues early?
• Do they communicate clearly in writing?

That often predicts how they’ll behave after the contract is signed.

7) Review legal and commercial terms carefully

Key contract points include:

• Exclusivity
• Capacity reservation
• Forecasting obligations
• MOQ and cancellation terms
• Quality agreement
• IP ownership
• Confidentiality
• Liability and indemnification
• Regulatory filing support
• Price adjustment clauses
• Termination rights
• Audit rights

For a new generic, make sure the contract does not leave you locked into poor service or exposed to hidden costs.

8) Visit the site and audit the operation

If feasible, do an on-site audit.

Inspect:

• Housekeeping and material flow
• Segregation of APIs and finished goods
• Equipment condition and maintenance
• QC lab capability
• Documentation practices
• Training records
• Warehousing and temperature controls
• Batch record execution
• Deviation management culture

What matters is not just whether the facility looks clean, but whether the quality systems actually work.

9) Ask for a pilot or demo batch if appropriate

For more complex products or risky transfers, pilot runs can reveal issues early.

Pilot work can help evaluate:

• Process reproducibility
• Yield
• Tablet hardness/friability or other critical quality attributes
• Stability
• Packaging compatibility
• Scale-up risks

A CMO that resists pilot work without a good reason may be overconfident or underprepared.

10) Use a scorecard

A simple weighted scorecard helps keep the decision objective.

Example categories:

• Technical fit — 30%
• Regulatory/quality track record — 25%
• Supply reliability — 15%
• Cost — 15%
• Communication/project management — 10%
• Commercial/legal terms — 5%

Score each provider on the same criteria and compare total weighted scores.
You can adjust weights depending on whether your biggest concern is launch speed, compliance, or cost.

11) Red flags to watch for

Be cautious if a provider:

• Promises very fast timelines without detail
• Gives unusually low pricing with vague assumptions
• Has repeated inspection problems
• Cannot explain process capabilities clearly
• Won’t provide references or audit access
• Has poor documentation discipline
• Suggests major changes without risk assessment
• Relies on a single source for key materials with no backup

12) Think beyond launch

For generics, your partner should support the product life cycle:

• Continued process verification
• Change management
• Cost reduction opportunities
• Additional market registrations
• Capacity expansion
• New pack configurations

The best provider is one you can grow with, not just launch with.

A practical selection approach

A good process is:

1. Define product and market requirements
2. Issue an RFI/RFQ with technical and quality questions
3. Screen out non-fits
4. Run audits on the short list
5. Request detailed commercial proposals
6. Score all options using a weighted matrix
7. Negotiate quality and supply terms
8. Choose the partner with the best risk-adjusted value

If you want, I can also help you build:

• a CMO selection scorecard
• an RFQ questionnaire
• or a due diligence checklist for generic product manufacturing providers.